1. Kelkar, N.S., ..., Ackerman, M.E., Humoral correlates of protection in DarDar trial, a phase 3 vaccine trial conducted in Bacillus Calmette Guérin-primed HIV infected adults who were boosted with inactivated whole cell-mycobacterial vaccine. (Submitted, available on bioRxiV)
2. Kelkar, N.S., Ackerman, M.E., Failing Better: How we might learn more from clinical and preclinical studies as we try again to achieve vaccine-mediated protection from HIV-1. (Submitted)
3. …, Kelkar, N.S.*,…, Ferrari, G., 2025. Computationally selected HIV-1 subtype C trivalent gp120 vaccine protects against heterologous SHIV challenge. Vaccines, p.231.
4. Kelkar, N.S., Goldberg, B.S., ..., Ackerman, M.E., 2024. Sex-and species-associated differences in complement-mediated immunity in humans and rhesus macaques. Mbio, pp.e00282-24.
5. Kelkar, N.S., Morrison, K.S., Ackerman, M.E., 2023. Foundations for improved vaccine correlate of risk analysis using positive-unlabeled learning. Human Vaccines & Immunotherapeutics, 19(1), p.2204020.
6. Kelkar, N. and Modak, S.P., 2018. The internal oligopeptide sequences missing in crystals are disordered domains. MOJ Proteomics Bioinform, 7(1), p.00215.
7. Putignano, A., Kelkar, N.S., …, Marchant, A., The humoral profile of immunoglobulins specific for microbiota antigens stratifies the severity of patients affected by alcohol-related liver disease and predicts their 90-d mortality. (Submitted)
8. Xu, S., Kelkar, N.S., Ackerman, M.E., 2024. Positive-Unlabeled learning to infer protection status and identify correlates in vaccine efficacy field trials. iScience, 27(3).
9. Gemander, N., …, Kelkar, N.S., …, Marchant, A., 2025. Covid-19 vaccine responses are influenced by distinct risk factors in naïve and SARS-CoV-2 experienced hemodialysis patients. Vaccine, 44, pp126544
10. Slein, M.D., …, Kelkar, N.S., …, Ackerman, M.E., 2024. Improving antibody-mediated protection against HSV infection by eliminating interactions with viral Fc receptor gE/gI. (Submitted, available on bioRxiV)
11. Gemander, N., ..., Kelkar, N.S., …, Marchant, A., 2024. Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), pp.635-648.
12. Slein, M.D., ..., Kelkar, N.S., …, Ackerman, M.E., 2024. Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D. Cell Reports Medicine, 5(2).
13. Ali, M.J., ..., Kelkar, N., …, Kaur, I., 2020. Alteration of tear cytokine expressions in primary acquired nasolacrimal duct obstruction–potential insights into the etiopathogenesis. Current Eye Research, 45(4), pp.435-439.
14. Ravishankar, V., Kelkar, N., …, Modak S.P., 2020. Distribution of short oligopeptides in a dataset of selected polypeptides. MOJ Proteomics Bioinform, 9(4), pp.91-94.
15. Deshmukh, A.B., …, Kelkar, N., …, Tamhane, V.A., 2018. De novo root transcriptome of a medicinally important rare tree Oroxylum indicum for characterization of the flavonoid biosynthesis pathway. Phytochemistry, 156, pp.201-213.
* indicates co-first author